Purple Biotech Ltd. — Capital/Financing Update 2021

Jun 10, 2021

_________ false

���� ����� ��"�	2 352
PURPLE BIOTECH LTD
Corporation no: 520031238	12724
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	10/06/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-098838	Time of broadcast: 08:20 08:20

---

Immediate report on other matterDon't use this form if there is more adequate one

PROSPECTUS SUPPLEMENT (to Prospectus dated December 13, 2019) Filed Pursuant to Rule 424(b)(5) Registration No. 333-235327 ����� ������ ������ �� ������ ����� ������ ���� �� ����� ����"� ���� ������� ��� ��� ����� ������ ����"� ������ ������ At The Market ��� �� ���� ����� ���� �� ����� ����� ����� ������ ������ ���� �� ������ ������ ���� �� �����, ��� ����� ����� �� ����� ������ ���� ��� ����� �� ���� �����, �� �� ����, ����� �� ����� ���� ����� ����� ���� ����� ���� ������ �� ���� �������� ����� ����� ������ ��� ��� ����� �� ���� ����� The submission by the Company to the Israel Securities Authority and the Tel Aviv Stock Exchange of a copy of a U.S. prospectus supplement originally filed by the Company with the United States Securities Exchange Commission pursuant to Rule 424(b)(5) filed should not be deemed an admission by the Company that such submission is required of the Company under the Securities Law 5728-1968 and the Securities Regulations (Periodic and Immediate Reports of Foreign Corporation) 5761-2000, nor an admission by the Company that this submission is necessarily being delivered pursuant to the aforesaid laws and regulations.
Attached file ea142421-424b5_purplebiotechEDGAR3_isa.pdf

����� ������ ���� �� �����
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 04/05/2021
Address: Oppenheimer, Science Park 4 , Rehovot 7670104   , Israel Tel: 03-9333121 , 03-9311321 Fax: 03-5097196
E-mail address: ir@purple-biotech.com   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMA LTD, KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: Masas Ludmer Adi Position of Signatory in the reporting corporation: Company Controller Name of Employer Company:
Address: Menachem Begin Drive 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: adim@kitovpharma.com 1
Israel